Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents

Vance L. Albaugh, Thomas C. Vary, Olga Ilkayeva, Brett R. Wenner, Kevin P. Maresca, John L. Joyal, Steven Breazeale, Tedd D. Elich, Charles H. Lang, Christopher J. Lynch

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Patients taking atypical antipsychotics are frequented by serious metabolic (eg, hyperglycemia, obesity, and diabetes) and cardiac effects. Surprisingly, chronic treatment also appears to lower free fatty acids (FFAs). This finding is paradoxical because insulin resistance is typically associated with elevated not lower FFAs. How atypical antipsychotics bring about these converse changes in plasma glucose and FFAs is unknown. Chronic treatment with olanzapine, a prototypical, side effect prone atypical antipsychotic, lowered FFA in Sprague-Dawley rats. Olanzapine also lowered plasma FFA acutely, concomitantly impairing in vivo lipolysis and robustly elevating whole-body lipid oxidation. Increased lipid oxidation was evident from accelerated losses of triglycerides after food deprivation or lipid challenge, elevated FFA uptake into most peripheral tissues (∼2-fold) except heart, rises in long-chain 3-hydroxylated acyl-carnitines observed in diabetes, and rapid suppression of the respiratory exchange ratio (RER) during the dark cycle. Normal rises in RER following refeeding, a sign of metabolic flexibility, were severely blunted by olanzapine. Increased lipid oxidation in muscle could be explained by ∼50% lower concentrations of the negative cytoplasmic regulator of carnitine palmitoyltransferase I, malonyl-CoA. This was associated with loss of anapleurotic metabolites and citric acid cycle precursors of malonyl-CoA synthesis rather than adenosine monophosphate-activated kinase activation or direct ACC1/2 inhibition. The ability of antipsychotics to lower dark cycle RER in mice corresponded to their propensities to cause metabolic side effects. Our studies indicate that lipocentric mechanisms or altered intermediary metabolism could underlie the FFA lowering and hyperglycemia (Randle cycle) as well as some of the other side effects of atypical antipsychotics, thereby suggesting strategies for alleviating them.

Original languageEnglish (US)
Pages (from-to)153-166
Number of pages14
JournalSchizophrenia Bulletin
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Nonesterified Fatty Acids
Antipsychotic Agents
olanzapine
Rodentia
Lipids
Malonyl Coenzyme A
Hyperglycemia
Carnitine O-Palmitoyltransferase
Food Deprivation
Aptitude
Citric Acid Cycle
Carnitine
Lipolysis
Adenosine Monophosphate
Sprague Dawley Rats
Insulin Resistance
Triglycerides
Phosphotransferases
Obesity
Glucose

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Cite this

Albaugh, V. L., Vary, T. C., Ilkayeva, O., Wenner, B. R., Maresca, K. P., Joyal, J. L., ... Lynch, C. J. (2012). Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophrenia Bulletin, 38(1), 153-166. https://doi.org/10.1093/schbul/sbq053
Albaugh, Vance L. ; Vary, Thomas C. ; Ilkayeva, Olga ; Wenner, Brett R. ; Maresca, Kevin P. ; Joyal, John L. ; Breazeale, Steven ; Elich, Tedd D. ; Lang, Charles H. ; Lynch, Christopher J. / Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. In: Schizophrenia Bulletin. 2012 ; Vol. 38, No. 1. pp. 153-166.
@article{6dd0fd9ffeae4005832c3f95d384ef5a,
title = "Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents",
abstract = "Patients taking atypical antipsychotics are frequented by serious metabolic (eg, hyperglycemia, obesity, and diabetes) and cardiac effects. Surprisingly, chronic treatment also appears to lower free fatty acids (FFAs). This finding is paradoxical because insulin resistance is typically associated with elevated not lower FFAs. How atypical antipsychotics bring about these converse changes in plasma glucose and FFAs is unknown. Chronic treatment with olanzapine, a prototypical, side effect prone atypical antipsychotic, lowered FFA in Sprague-Dawley rats. Olanzapine also lowered plasma FFA acutely, concomitantly impairing in vivo lipolysis and robustly elevating whole-body lipid oxidation. Increased lipid oxidation was evident from accelerated losses of triglycerides after food deprivation or lipid challenge, elevated FFA uptake into most peripheral tissues (∼2-fold) except heart, rises in long-chain 3-hydroxylated acyl-carnitines observed in diabetes, and rapid suppression of the respiratory exchange ratio (RER) during the dark cycle. Normal rises in RER following refeeding, a sign of metabolic flexibility, were severely blunted by olanzapine. Increased lipid oxidation in muscle could be explained by ∼50{\%} lower concentrations of the negative cytoplasmic regulator of carnitine palmitoyltransferase I, malonyl-CoA. This was associated with loss of anapleurotic metabolites and citric acid cycle precursors of malonyl-CoA synthesis rather than adenosine monophosphate-activated kinase activation or direct ACC1/2 inhibition. The ability of antipsychotics to lower dark cycle RER in mice corresponded to their propensities to cause metabolic side effects. Our studies indicate that lipocentric mechanisms or altered intermediary metabolism could underlie the FFA lowering and hyperglycemia (Randle cycle) as well as some of the other side effects of atypical antipsychotics, thereby suggesting strategies for alleviating them.",
author = "Albaugh, {Vance L.} and Vary, {Thomas C.} and Olga Ilkayeva and Wenner, {Brett R.} and Maresca, {Kevin P.} and Joyal, {John L.} and Steven Breazeale and Elich, {Tedd D.} and Lang, {Charles H.} and Lynch, {Christopher J.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1093/schbul/sbq053",
language = "English (US)",
volume = "38",
pages = "153--166",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "1",

}

Albaugh, VL, Vary, TC, Ilkayeva, O, Wenner, BR, Maresca, KP, Joyal, JL, Breazeale, S, Elich, TD, Lang, CH & Lynch, CJ 2012, 'Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents', Schizophrenia Bulletin, vol. 38, no. 1, pp. 153-166. https://doi.org/10.1093/schbul/sbq053

Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. / Albaugh, Vance L.; Vary, Thomas C.; Ilkayeva, Olga; Wenner, Brett R.; Maresca, Kevin P.; Joyal, John L.; Breazeale, Steven; Elich, Tedd D.; Lang, Charles H.; Lynch, Christopher J.

In: Schizophrenia Bulletin, Vol. 38, No. 1, 01.01.2012, p. 153-166.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents

AU - Albaugh, Vance L.

AU - Vary, Thomas C.

AU - Ilkayeva, Olga

AU - Wenner, Brett R.

AU - Maresca, Kevin P.

AU - Joyal, John L.

AU - Breazeale, Steven

AU - Elich, Tedd D.

AU - Lang, Charles H.

AU - Lynch, Christopher J.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Patients taking atypical antipsychotics are frequented by serious metabolic (eg, hyperglycemia, obesity, and diabetes) and cardiac effects. Surprisingly, chronic treatment also appears to lower free fatty acids (FFAs). This finding is paradoxical because insulin resistance is typically associated with elevated not lower FFAs. How atypical antipsychotics bring about these converse changes in plasma glucose and FFAs is unknown. Chronic treatment with olanzapine, a prototypical, side effect prone atypical antipsychotic, lowered FFA in Sprague-Dawley rats. Olanzapine also lowered plasma FFA acutely, concomitantly impairing in vivo lipolysis and robustly elevating whole-body lipid oxidation. Increased lipid oxidation was evident from accelerated losses of triglycerides after food deprivation or lipid challenge, elevated FFA uptake into most peripheral tissues (∼2-fold) except heart, rises in long-chain 3-hydroxylated acyl-carnitines observed in diabetes, and rapid suppression of the respiratory exchange ratio (RER) during the dark cycle. Normal rises in RER following refeeding, a sign of metabolic flexibility, were severely blunted by olanzapine. Increased lipid oxidation in muscle could be explained by ∼50% lower concentrations of the negative cytoplasmic regulator of carnitine palmitoyltransferase I, malonyl-CoA. This was associated with loss of anapleurotic metabolites and citric acid cycle precursors of malonyl-CoA synthesis rather than adenosine monophosphate-activated kinase activation or direct ACC1/2 inhibition. The ability of antipsychotics to lower dark cycle RER in mice corresponded to their propensities to cause metabolic side effects. Our studies indicate that lipocentric mechanisms or altered intermediary metabolism could underlie the FFA lowering and hyperglycemia (Randle cycle) as well as some of the other side effects of atypical antipsychotics, thereby suggesting strategies for alleviating them.

AB - Patients taking atypical antipsychotics are frequented by serious metabolic (eg, hyperglycemia, obesity, and diabetes) and cardiac effects. Surprisingly, chronic treatment also appears to lower free fatty acids (FFAs). This finding is paradoxical because insulin resistance is typically associated with elevated not lower FFAs. How atypical antipsychotics bring about these converse changes in plasma glucose and FFAs is unknown. Chronic treatment with olanzapine, a prototypical, side effect prone atypical antipsychotic, lowered FFA in Sprague-Dawley rats. Olanzapine also lowered plasma FFA acutely, concomitantly impairing in vivo lipolysis and robustly elevating whole-body lipid oxidation. Increased lipid oxidation was evident from accelerated losses of triglycerides after food deprivation or lipid challenge, elevated FFA uptake into most peripheral tissues (∼2-fold) except heart, rises in long-chain 3-hydroxylated acyl-carnitines observed in diabetes, and rapid suppression of the respiratory exchange ratio (RER) during the dark cycle. Normal rises in RER following refeeding, a sign of metabolic flexibility, were severely blunted by olanzapine. Increased lipid oxidation in muscle could be explained by ∼50% lower concentrations of the negative cytoplasmic regulator of carnitine palmitoyltransferase I, malonyl-CoA. This was associated with loss of anapleurotic metabolites and citric acid cycle precursors of malonyl-CoA synthesis rather than adenosine monophosphate-activated kinase activation or direct ACC1/2 inhibition. The ability of antipsychotics to lower dark cycle RER in mice corresponded to their propensities to cause metabolic side effects. Our studies indicate that lipocentric mechanisms or altered intermediary metabolism could underlie the FFA lowering and hyperglycemia (Randle cycle) as well as some of the other side effects of atypical antipsychotics, thereby suggesting strategies for alleviating them.

UR - http://www.scopus.com/inward/record.url?scp=84555188648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84555188648&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbq053

DO - 10.1093/schbul/sbq053

M3 - Article

C2 - 20494946

AN - SCOPUS:84555188648

VL - 38

SP - 153

EP - 166

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 1

ER -